Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review ; volume:20 ; number:1 ; day:17 ; month:10 ; year:2022 ; pages:1-15 ; date:12.2022
Pediatric rheumatology ; 20, Heft 1 (17.10.2022), 1-15, 12.2022
- Creator
-
Li, Yandie
Yu, Meiping
Lu, Meiping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-022-00728-0
- URN
-
urn:nbn:de:101:1-2023010221043466495407
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Yandie
- Yu, Meiping
- Lu, Meiping
- SpringerLink (Online service)
Other Objects (12)
Cutaneous manifestations of autoinflammatory diseases
The expanding spectrum of rare monogenic autoinflammatory diseases
Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
Autoinflammatory Keratinization Diseases—The Concept, Pathophysiology, and Clinical Implications
Systemic autoinflammatory disease and genetic testing
NLRP12-associated systemic autoinflammatory diseases in children
Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
Pathophysiology and therapy of systemic vasculitides
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
Cutaneous manifestations of autoinflammatory diseases
The expanding spectrum of rare monogenic autoinflammatory diseases
Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
Autoinflammatory Keratinization Diseases—The Concept, Pathophysiology, and Clinical Implications
Systemic autoinflammatory disease and genetic testing
NLRP12-associated systemic autoinflammatory diseases in children
Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
Pathophysiology and therapy of systemic vasculitides
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
Cutaneous manifestations of autoinflammatory diseases
The expanding spectrum of rare monogenic autoinflammatory diseases
Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
Autoinflammatory Keratinization Diseases—The Concept, Pathophysiology, and Clinical Implications
Systemic autoinflammatory disease and genetic testing
NLRP12-associated systemic autoinflammatory diseases in children
Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
Pathophysiology and therapy of systemic vasculitides